牛牛AI助理已提取核心訊息
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 7, 2024, Klinger acquired 1,138 shares through the exercise of derivative securities. The following day, on March 8, 2024, she sold 544 shares on the open market at a price of $99.0509 per share, resulting in a total sale value of $53,883.69. After these transactions, Klinger's direct holdings in Moderna common stock amounted to 9,267 shares.
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 7, 2024, Klinger acquired 1,138 shares through the exercise of derivative securities. The following day, on March 8, 2024, she sold 544 shares on the open market at a price of $99.0509 per share, resulting in a total sale value of $53,883.69. After these transactions, Klinger's direct holdings in Moderna common stock amounted to 9,267 shares.
Moderna的首席法務官香農·泰裏姆·克林格完成了一系列涉及該公司普通股的交易。2024年3月7日，克林格通過行使衍生證券收購了1,138股股票。第二天，即2024年3月8日，她在公開市場上以每股99.0509美元的價格出售了544股股票，總銷售價值爲53,883.69美元。在這些交易之後，克林格直接持有的Moderna普通股爲9,267股。
Moderna的首席法務官香農·泰裏姆·克林格完成了一系列涉及該公司普通股的交易。2024年3月7日，克林格通過行使衍生證券收購了1,138股股票。第二天，即2024年3月8日，她在公開市場上以每股99.0509美元的價格出售了544股股票，總銷售價值爲53,883.69美元。在這些交易之後，克林格直接持有的Moderna普通股爲9,267股。
有用
沒用